PHENTOLAMINE

Test Ligands Values Explained

Test Ligand ID - A unique identifier for the test ligand
Ligand Name - Name of the test ligand

Test Ligand ID1479
Ligand NamePHENTOLAMINE
PubMed Compound Id91430
StructureProduct Image
Molecular FormulaC18H23N3O4S
Molecular Weight377.5
SMILESCC1=CC=C(C=C1)N(CC2=NCCN2)C3=CC(=CC=C3)O.CS(=O)(=O)O
SynonymsPhentolamine mesylate
65-28-1
phentolamine mesilate
Phentolamine methanesulfonate
OraVerse
Mesylate phentolamine
RYZUMVI
NV-101
Y7543E5K9T
DTXSID60215315
Mesilate, Phentolamine
Mesylate, Phentolamine
RefChem:55851
Methanesulfonate, Phentolamine
DTXCID60137806
2-(N-p'-Tolyl-N-(m'-hydroxyphenyl)aminomethyl)imidazoline Monomethanesulfonate
200-604-6
Phentolamine (mesylate)
Phentolamine methanesulfonate salt
MFCD00134201
Phenol,3-[[(4,5-dihydro-1H-imidazol-2-yl)methyl](4-methylphenyl)amino]-,monomethanesulfonate (salt)
3-(((4,5-dihydro-1H-imidazol-2-yl)methyl)(p-tolyl)amino)phenol methanesulfonate
Phentolamine mesylate [USP]
MLS000069487
Regitine mesylate
m-(N-(2-Imidazolin-2-ylmethyl)-p-toluidino)phenol monomethanesulfonate (salt)
Phenol, 3-(((4,5-dihydro-1H-imidazol-2-yl)methyl)(4-methylphenyl)amino)-, monomethanesulfonate (salt)
SMR000059054
3-[N-(4,5-dihydro-1H-imidazol-2-ylmethyl)-4-methylanilino]phenol;methanesulfonic acid
Phentolamine mesylate (USP)
Vasomax
Regitin methanesulphonate
Regitine methanesulfonate
Phenol, m-[N-(2-imidazolin-2-ylmethyl)-p-toluidino]-, methanesulfonate (1:1)
Phentolamine methanesulphonate
CCRIS 9022
Phentolamine mesilate [INN:BAN]
EINECS 200-604-6
Vasofem
UNII-Y7543E5K9T
Regitin mesylate
SR-01000000055
Regitine (TN)
Z-Max
3-[N-(4,5-dihydro-1H-imidazol-2-ylmethyl)-4-methylanilino]phenol
Opera_ID_1599
Lopac-P-7561
SCHEMBL40852
MLS001076484
Phentolamine, methyl sulfonate
REGID_for_CID_91430
HY-B0362AR
orb1309154
CHEMBL1200873
HY-B0362A
Phentolamine mesilate (JAN/INN)
OGIYDFVHFQEFKQ-UHFFFAOYSA-N
HMS2233A24
HMS3263E05
HMS3373D03
HMS3655B13
HMS3884A22
HMS5080B19
PHENTOLAMINE MESILATE [JAN]
Phentolamine (mesylate) (Standard)
MSK10275X-100M
Tox21_500982
PHENTOLAMINE MESYLATE [VANDF]
s2038
PHENTOLAMINE MESILATE [MART.]
AKOS007930193
PHENTOLAMINE MESILATE [WHO-DD]
PHENTOLAMINE MESYLATE [USP-RS]
AC-7472
CCG-222286
FP26896
LP00982
3-[N-(4,5-dihydro-1H-imidazol-2-ylmethyl)-4-methylanilino]phenol; methanesulfonic acid
Phenol, m-(N-(2-imidazolin-2-ylmethyl)-p-toluidino)-, monomethanesulfonate (salt)
NCGC00016195-01
NCGC00016195-02
NCGC00094282-01
NCGC00261667-01
AS-13800
PHENTOLAMINE METHANESULFONATE [MI]
ST057364
PHENTOLAMINE MESYLATE [ORANGE BOOK]
PHENTOLAMINE MESILATE [EP MONOGRAPH]
EU-0100982
NS00078829
P1985
PHENTOLAMINE MESYLATE [USP MONOGRAPH]
SW196637-3
D00509
P 7561
T72782
134P201
A835046
EN300-19630478
SR-01000000055-3
Phentolamine mesylate Solution in Methanol, 100ug/mL
Q27294332
Phentolamine methanesulfonate salt, >=98% (TLC), powder
Phentolamine mesilate, British Pharmacopoeia (BP) Reference Standard
2-[N-(m-Hydroxyphenyl)-p-toluidinomethyl]imidazoline Methanesulfonate
2-[N-(m-Hydroxyphenyl)-p-toluidinomethyl]imidazoline, methanesulfonate
Phentolamine mesilate, European Pharmacopoeia (EP) Reference Standard
Phentolamine mesylate, United States Pharmacopeia (USP) Reference Standard
3-(((4,5-dihydro-1H-imidazol-2-yl)methyl)(p-tolyl)amino)phenolmethanesulfonate
3-[(2-imidazolin-2-ylmethyl)(4-methylphenyl)amino]phenol, methanesulfonic acid
3-[4,5-dihydro-1H-imidazol-2-ylmethyl-(4-methylphenyl)amino]phenol; methanesulfonic acid
3-[N-(4,5-dihydro-1H-imidazol-1-ium-2-ylmethyl)-4-methylanilino]phenol;methanesulfonate
3-[N-(4,5-dihydro-1H-imidazol-2-ylmethyl)-4-methyl-anilino]phenol;methanesulfonic acid
M-(N-(2-IMIDAZOLIN-2-YLMETHYL)-P-TOLUIDINO)PHENOL MONOMETHANESULPHONATE (SALT)
Phentolamine mesilate for system suitability, European Pharmacopoeia (EP) Reference Standard
Phentolamine Mesylate, Pharmaceutical Secondary Standard; Certified Reference Material
3-{[(4,5-dihydro-1H-imidazol-2-yl)methyl](4-methylphenyl)amino}phenol; methanesulfonic acid
PHENOL, 3-(((4,5-DIHYDRO-1H-IMIDAZOL-2-YL)METHYL)(4-METHYLPHENYL)AMINO)-, MONOMETHANESULPHONATE (SALT)
Created AtJan 13, 2025 2:47 pm
Updated AtJan 13, 2025 2:47 pm